Description

3β,15α-Dihydroxy-11,23-Dioxo-5α-Lanost-8-En-26-Oic Acid is a highly functionalized lanostane-type triterpenoid derivative, valued as a critical intermediate in advanced pharmaceutical synthesis and biochemical research. Its complex, multi-functional structure makes it a versatile scaffold for developing novel therapeutic agents and conducting structure-activity relationship (SAR) studies. This compound is primarily sought by research institutions and pharmaceutical companies focused on anti-inflammatory, antiviral, and metabolic pathway modulation.

Application

• Pharmaceutical Intermediate: A key building block for the synthesis of novel steroidal and triterpenoid-based drug candidates targeting specific biological pathways.
• Biochemical Research: Used as a reference standard or probe in enzymatic studies and receptor binding assays to investigate lanostane-related biological activities.
• Anti-inflammatory Agent Development: Serves as a precursor for compounds being evaluated for their potential to modulate inflammatory mediators like cytokines.
• Natural Product Synthesis: An important intermediate in the semi-synthesis or total synthesis of complex natural products with lanostane skeletons.
• Metabolic Pathway Studies: Employed in research focused on cholesterol biosynthesis and other sterol metabolic pathways due to its structural similarity.
• Academic & Discovery Chemistry: Utilized in medicinal chemistry programs for lead optimization and the creation of specialized chemical libraries.

Basic Information

Product Name	3β,15α-Dihydroxy-11,23-Dioxo-5α-Lanost-8-En-26-Oic Acid
CAS No.	98683-75-1
Molecular Formula	C30H44O6
Molecular Weight	500.67 g/mol
Synonyms	3β,15α-Dihydroxy-11,23-dioxo-5α-lanost-8-en-26-oic acid; (5α)-3β,15α-Dihydroxy-11,23-dioxolanost-8-en-26-oic Acid; Lanost-8-ene-3β,15α-diol-11,23-dione-26-oic Acid; 3β,15α-Dihydroxy-11,23-dioxo-5α-lanost-8-en-26-oate; 98683-75-1; Triterpenoid acid derivative; Functionalized lanostane
EINECS	Contact for details

Quality Control

Our 3β,15α-Dihydroxy-11,23-Dioxo-5α-Lanost-8-En-26-Oic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for research and pharmaceutical development. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept in a well-ventilated area and protected from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 95.0%
Purity (HPLC, Area %)	≥ 97.0%
Loss on Drying	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.